Pharma focus The Amundsen Group specializes in strategy and analytics for the U.S. pharmaceutical industry, presenting targeted opportunities to offer advanced market insights, pricing strategy, and commercial analytics consulting to pharma clients undergoing industry-wide transformations.

Growth potential With a revenue range of 10M–25M and a headcount of 51–200, there is room to expand services to larger pharma organizations or to support expanding Managed Markets capabilities within IMS Health relationships, leveraging established credibility in the space.

Part of IMS Having become part of the IMS Health family since 2013, there may be collaboration and cross-sell opportunities with IMS Health’s broader managed markets and services resources to deliver integrated solutions.

Tech readiness Existing cloud-enabled infrastructure (Cloudflare) suggests a baseline for digital engagement and security, enabling scalable analytics offerings and potential acceleration of client-facing dashboards or data platforms.

Competitive landscape Operate alongside large contract research and consulting players with substantial scale; emphasize niche specialization in commercial issues for pharma and leverage senior leadership experience to differentiate in advisory, pricing, and market access analytics.